Are patients getting their GLP-1s for the lowest price possible?

Download our full data brief on GLP-1 prescription prices.

DoseSpot Illustration - The DoseSpot Difference_Final

Discover the hidden costs - and the missed savings opportunities in our latest GLP-1 Data Brief.

What the data from DoseSpot reveals:

  • 1 in 8 American adults are using GLP-1s, yet many are overpaying
  • 70% of GLP-1s come from manufacturers, not compounding pharmacies
  • Medication adherence plummets after just 6 months
  • 1 in 5 health plans cover GLP-1s for weight loss
  • $7 million in savings could've been delivered with available programs

Fill out the form below to access the full overview.

DoseSpot GLP-1 Data Brief_thumbnail
Complete this form to download the brief